Medication errors involving oral chemotherapy

Cancer

Volumn 116, Issue 10, 2010, Pages 2455-2464

  Weingart, Saul N ^a,b   Toro, Julio ^c,d   Spencer, Justin ^a   Duncombe, Deborah ^a   Gross, Anne ^a,c,d   Bartel, Sylvia ^a   Miransky, Jeremy ^e   Partridge, Ann ^a,b   Shulman, Lawrence N ^a,b   Connor, Maureen ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d UNIVERSITY OF MASSACHUSETTS BOSTON   (United States)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Adverse drug events; Incident reports; Medication errors; Oral chemotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; ANTITUSSIVE AGENT; BENZONATATE; CAPECITABINE; CYCLOPHOSPHAMIDE; IMATINIB; MATERNA; MERCAPTOPURINE; METOCLOPRAMIDE; MULTIVITAMIN; PROCARBAZINE; PROPYLTHIOURACIL; TEMOZOLOMIDE; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ADVERSE OUTCOME; ARTICLE; BONE MARROW SUPPRESSION; BREAST CANCER; CANCER CHEMOTHERAPY; CHILD; CHILDHOOD CANCER; CLINICAL PROTOCOL; COMPUTERIZED ORDER ENTRY SYSTEM; CONTROLLED STUDY; DRUG DOSE TITRATION; DRUG FATALITY; DRUG HYPERSENSITIVITY; DRUG OVERDOSE; DRUG WITHDRAWAL; FAMILY; FOLLOW UP; FRIEND; GASTROINTESTINAL TOXICITY; HOSPITAL INFORMATION SYSTEM; HUMAN; INCIDENT REPORT; LIVER TOXICITY; MAJOR CLINICAL STUDY; MEDICAL DOCUMENTATION; MEDICAL LITERATURE; MEDICAL SPECIALIST; MEDICATION ERROR; MULTIPLE CYCLE TREATMENT; NAUSEA; NURSE; ONCOLOGY; PATIENT CARE; PATIENT COMPLIANCE; PATIENT MONITORING; PATIENT SAFETY; PHARMACIST; PHYSICIAN; PREGNANT WOMAN; PRESCRIPTION; PRIORITY JOURNAL; RISK MANAGEMENT; SPONTANEOUS ABORTION; THYROID DISEASE; DRUG MONITORING; DRUG SURVEILLANCE PROGRAM; DRUG TOXICITY; INCIDENCE; ORAL DRUG ADMINISTRATION; STATISTICS;

ADMINISTRATION, ORAL; ADVERSE DRUG REACTION REPORTING SYSTEMS; ANTINEOPLASTIC AGENTS; DRUG MONITORING; DRUG TOXICITY; HUMANS; INCIDENCE; MEDICATION ERRORS; PRESCRIPTIONS;

EID: 77952572242     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25027     Document Type: Article

References (27)

1. Weingart SN, Brown E, Bach PB, et al. NCCN Task Force Report: oral chemotherapy. J Natl Compr Canc Netw. 2008;6(suppl 3):S1-S14.
2. Weingart SN, Flug J, Brouillard D, et al. Oral chemotherapy safety practices at US cancer centres: questionnaire survey. BMJ. 2007;334:407-409. (Pubitemid 46374648)
3. World Health Organization. World Alliance for Patient Safety: WHO Draft Guidelines for Adverse Event Reporting and Learning Systems. Available at: http://www.who.int/patientsafety/events/05/Reporting-Guidelines.pdf Accessed July 1, 2009.
4. Weingart SN, Ship AN, Aronson MD. Confidential clinician-reported surveillance of adverse events among medical inpatients. J Gen Intern Med. 2000;15:470-477.
5. Weingart SN, Callanan LD, Ship AN, et al. A physician-based voluntary reporting system for adverse events and medical errors. J Gen Intern Med. 2001;16:809-814. (Pubitemid 34015695)
6. Bates DW, Boyle DL, Vander Vliet MB, et al. Relationship between medication errors and adverse drug events. J Gen Intern Med. 1995;10:199-205.
7. Bates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA. 1995;274:29-34.
8. Gandhi TK, Weingart SN, Borus J, et al. Adverse drug events in ambulatory care. N Engl J Med. 2003;348:1555-1564.
9. Leape LL, Brennan TA, Laird N, et al. The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II. N Engl J Med. 1991;324:377-384.
10. Borner M, Schoffski P, de Wit R, et al. Patient preferences and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin: a randomised crossover trial in advanced colorectal cancer. Eur J Cancer. 2002;38:349-358.
11. Liu G, Franssen E, Fitch MI, et al. Patient preferences for oral versus intravenous palliative chemotherapy. J Clin Oncol. 1997;15:110-115.
12. Kaushal R, Bates DW, Landrigan C, et al. Medication errors and adverse drug events in pediatric inpatients. JAMA. 2001;285:2114-2120. (Pubitemid 32367829)
13. Gurwitz JH, Field TS, Harrold LR, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA. 2003;289:1107-1116.
14. Partridge AH, Wang PS, Winer EP, et al. Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. J Clin Oncol. 2003;21:602-606. (Pubitemid 46621892)
15. Taylor JA, Winter L, Geyer LJ, et al. Oral outpatient chemotherapy medication errors in children with acute lymphoblastic leukemia. Cancer. 2006;107:1400-1406. (Pubitemid 44452791)
16. Walsh KE, Dodd KS, Seetharaman K, et al. Medication errors among adults and children with cancer in the outpatient setting. J Clin Oncol. 2009;27:891-896.
17. Partridge AH, LaFountain A, Mayer E, et al. Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer. J Clin Oncol. 2008;26:556-562. (Pubitemid 351264348)
18. UK National Patient Safety Agency. Risks of incorrect dosing of oral anti-cancer medicines. Rapid Response Report NPSA/2008/RRR001, January 22, 2008. Available at: http://www.npsa.nhs.uk/EasySiteWeb/GatewayLink.aspx?alId=7494 Accessed July 1, 2009.
19. Leape LL. Error in medicine. JAMA. 1994;272:1851-1857.
20. Leape LL, Kabcenell A, Berwick DM, et al. Reducing Adverse Drug Events. Boston, MA: Institute for Healthcare Improvement; 1998.
21. National Comprehensive Cancer Center Network. NCCN Chemotherapy Order Templates. Available at: http://www.nccn.org/ordertemplates/default.asp Accessed July 1, 2009.
22. Shulman LN, Miller RS, Ambinder EP, et al. Principles of safe practice using an oncology EHR system for chemotherapy ordering, preparation, and administration, pt 1 of 2. J Oncol Pract. 2008;4:203-206.
23. Leape LL. Reporting of adverse events. N Engl J Med. 2002;347:1633-1638.
24. Cullen DJ, Bates DW, Small SD, et al. The incident reporting system does not detect adverse drug events: a problem for quality improvement. Jt Comm J Qual Improv. 1995;21:541-548.
25. Gallagher TH, Waterman AD, Garbutt JM, et al. US and Canadian physicians' attitudes and experiences regarding disclosing errors to patients. Arch Intern Med. 2006;66:1605-1611.
26. Garbutt J, Brownstein DR, Klein EJ, et al. Reporting and disclosing medical errors: pediatricians' attitudes and behaviors. Arch Pediatr Adolesc Med. 2007;161:179-185.
27. Localio AR, Weaver SL, Landis JR, et al. Identifying adverse events caused by medical care: degree of physician agreement in a retrospective chart review. Ann Intern Med. 1996;125:457-464.